Quick Takeaways
- BNGO - Bionano Genomics, Inc. has 18 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 18 Insiders of Bionano Genomics, Inc.
- Symbol
- BNGO on Nasdaq
- Location
- San Diego, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
There are no Buy or Sell transactions made by insiders since 07 Apr 2025
Bionano Genomics, Inc. executives and other stock owners filed with the SEC include:
Recent Insider Transactions by Companies or Individuals for Bionano Genomics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alka Chaubey | BNGO | Common Stock | Tax liability | -2.72% | -18 | 644 | 17 Feb 2026 | Direct | ||
| Mark Adamchak | BNGO | Common Stock | Tax liability | -1.14% | -3 | 260 | 17 Feb 2026 | Direct | ||
| Jonathan Dixon V | BNGO | Common Stock | Tax liability | -2.23% | -6 | 263 | 17 Feb 2026 | Direct | ||
| Mark Oldakowski | BNGO | Common Stock | Tax liability | -2.19% | -20 | 895 | 17 Feb 2026 | Direct | ||
| R. Erik Holmlin | BNGO | Common Stock | Tax liability | -2.99% | -51 | 1,657 | 17 Feb 2026 | Direct | ||
| Mark Adamchak | BNGO | Stock Option (Right to Buy) | Award | 10,890 | 10,890 | 02 Feb 2026 | Direct | |||
| Jonathan Dixon V | BNGO | Stock Option (Right to Buy) | Award | 26,117 | 26,117 | 02 Feb 2026 | Direct | |||
| Alka Chaubey | BNGO | Stock Option (Right to Buy) | Award | 27,737 | 27,737 | 02 Feb 2026 | Direct | |||
| Mark Oldakowski | BNGO | Stock Option (Right to Buy) | Award | 27,737 | 27,737 | 02 Feb 2026 | Direct | |||
| R. Erik Holmlin | BNGO | Stock Option (Right to Buy) | Award | 69,484 | 69,484 | 02 Feb 2026 | Direct | |||
| Mark Oldakowski | BNGO | Common Stock | Tax liability | -6.06% | -59 | 915 | 11 Sep 2025 | Direct | ||
| Alka Chaubey | BNGO | Common Stock | Tax liability | -7.15% | -51 | 662 | 11 Sep 2025 | Direct | ||
| Christopher J. Twomey | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| Kristiina Vuori MD | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| Yvonne Linney | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| Albert Luderer | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| David L. Barker | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| Hannah Mamuszka | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| Aleksandar Rajkovic | BNGO | Stock Option (Right to Buy) | Award | 2,775 | 2,775 | 11 Jun 2025 | Direct | |||
| Mark Oldakowski | BNGO | Common Stock | Tax liability | -2.7% | -27 | 974 | 03 Jun 2025 | Direct | ||
| Mark Adamchak | BNGO | Common Stock | Tax liability | -2.59% | -7 | 263 | 03 Jun 2025 | Direct | ||
| Alka Chaubey | BNGO | Common Stock | Tax liability | -3.26% | -24 | 713 | 03 Jun 2025 | Direct | ||
| R. Erik Holmlin | BNGO | Common Stock | Tax liability | -4.21% | -75 | 1,708 | 03 Jun 2025 | Direct | ||
| Jonathan Dixon V | BNGO | Common Stock | Tax liability | -8.5% | -25 | 269 | 03 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.